- Home
- LMFA vs CLRB Comparison
LMFA vs CLRB Comparison
Compare LMFA & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- CLRB
- Stock Information
- Founded
- LMFA 2008
- CLRB 2002
- Country
- LMFA United States
- CLRB United States
- Employees
- LMFA N/A
- CLRB N/A
- Industry
- LMFA Finance: Consumer Services
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- CLRB Health Care
- Exchange
- LMFA Nasdaq
- CLRB Nasdaq
- Market Cap
- LMFA 9.2M
- CLRB 10.7M
- IPO Year
- LMFA 2015
- CLRB N/A
- Fundamental
- Price
- LMFA $2.28
- CLRB $0.25
- Analyst Decision
- LMFA Hold
- CLRB Buy
- Analyst Count
- LMFA 1
- CLRB 2
- Target Price
- LMFA N/A
- CLRB $28.00
- AVG Volume (30 Days)
- LMFA 149.6K
- CLRB 3.9M
- Earning Date
- LMFA 11-13-2024
- CLRB 11-18-2024
- Dividend Yield
- LMFA N/A
- CLRB N/A
- EPS Growth
- LMFA N/A
- CLRB N/A
- EPS
- LMFA N/A
- CLRB N/A
- Revenue
- LMFA $12,838,084.00
- CLRB N/A
- Revenue This Year
- LMFA N/A
- CLRB N/A
- Revenue Next Year
- LMFA N/A
- CLRB N/A
- P/E Ratio
- LMFA N/A
- CLRB N/A
- Revenue Growth
- LMFA 27.81
- CLRB N/A
- 52 Week Low
- LMFA $2.19
- CLRB $0.23
- 52 Week High
- LMFA $6.11
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- LMFA 34.52
- CLRB 5.84
- Support Level
- LMFA $2.67
- CLRB $0.23
- Resistance Level
- LMFA $2.90
- CLRB $0.28
- Average True Range (ATR)
- LMFA 0.25
- CLRB 0.07
- MACD
- LMFA -0.06
- CLRB -0.11
- Stochastic Oscillator
- LMFA 8.49
- CLRB 1.41
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.